Association of Lower Extremity Lymphedema and Nonmelanoma Skin Cancers

Review Dermatology

Stewart-Treves syndrome and other cutaneous malignancies in the context of chronic lymphedema: a systematic review

Patrick J. Kim et al.

Summary: Angiosarcoma developing in chronically lymphedematous tissue, or Stewart-Treves syndrome (STS), is a rare and lethal complication of lymphedema. This systematic review analyzed characteristics and outcomes of STS and other cutaneous malignancies arising in chronic lymphedema. STS had a mean onset age of 61.2 years, with a mortality rate of 53.9% and remission rate of 16.1%, while other malignancies in lymphedema had a lower mortality rate of 10.5% and higher remission rate of 31.6%.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2022)

添加到收藏夹

Article Surgery

The American venous forum, American vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment

Fedor Lurie et al.

Summary: This study assessed experts' opinions on the available literature on lymphedema and found consensus on risk factors and diagnosis, but disagreement on treatment methods.

PHLEBOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

The incidence and clinical analysis of non-melanoma skin cancer

Magdalena Ciazynska et al.

Summary: Non-melanoma skin cancers, particularly basal cell carcinoma, are the most common malignancies in Caucasian populations. This study in Poland analyzed the incidence of primary BCCs and SCCs over a 20-year period, finding that BCC accounted for the majority of cases and SCC patients were typically older. Different subtypes of BCC and SCC showed varied prevalence on different anatomical sites.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Dermatology

Validity of Using Billing Codes From Electronic Health Records to Estimate Skin Cancer Counts

Nimay Anand et al.

Summary: This study found that ICD codes were not a good proxy measure for the number of skin cancers per patient, while CPT codes accounted for more than 75% of the variability in the number of skin cancers and were a better proxy measure for the total number of skin cancers per patient.

JAMA DERMATOLOGY (2021)

添加到收藏夹

Article Surgery